Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Zumiez Inc. Reports Holiday 2024 Sales Results
-
BioStem Technologies Announces Record Preliminary Fourth Quarter Net Revenue of $102.9 Million, with Full-Year 2024 Net Revenue Expected to Reach $301.8 Million
-
First Watch Restaurant Group, Inc. Reports Preliminary Operational Metrics for the Fourth Quarter and Fiscal Year 2024
-
Cartesian Therapeutics Highlights Progress and 2025 Strategic Priorities Across Pipeline of mRNA Cell Therapies for Autoimmune Diseases
-
Chimerix to Speak Today at The White House Cancer Moonshot Forum
-
Denny’s Corporation Releases Preliminary Financial Results for Fourth Quarter and Fiscal Year 2024
-
Nevada Lithium to Participate in the “2025 Mining Conference: Mining and Supplying Critical Minerals & Precious Metals”
-
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2024 Revenue
-
Agios Announces Key 2025 Milestones for Innovative Rare Disease Portfolio
-
Microbix & API Ensuring Flu Tests Can Detect H5N1 Strain
-
Fusion Fuel Closes on $1.28 Million Senior Convertible Notes and $25 Million Equity Line of Credit
-
Nurix Therapeutics Outlines 2025 Goals and Objectives for Advancement of Its Robust Pipeline in Cancer and Autoimmune Diseases
-
Abercrombie & Fitch Co. Increases Fourth Quarter and Full Year Net Sales Outlook on Better-Than-Expected Holiday Sales
-
EyePoint Provides Company Update and Anticipated Development Milestones for 2025
-
Sono-Tek Reports Third Quarter and Nine Months Fiscal 2025 Financial Results
-
Stingray to Release its Financial Results for the Third Quarter of Fiscal 2025
-
Atea Pharmaceuticals to Highlight 2025 Strategic Priorities at the 43rd Annual J.P. Morgan Healthcare Conference
-
ClearView Healthcare Partners Makes Strategic Investment in Epistemic AI to Advance Next-Generation Biomedical AI Platform
-
Barrick Recommends Shareholders Reject TRC Capital’s Below-Market “Mini-Tender” Offer for Common Shares
-
CytoSorbents Strengthens Balance Sheet with Closing of Oversubscribed Rights Offering
-
Greenwich LifeSciences Partners with Unicancer Expanding Flamingo-01 into France
-
Bunker Hill Provides Project and Corporate Update
-
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook
-
Aduro Clean Technologies to Ring the Nasdaq Closing Bell on Friday, January 17th, 2025
-
Axsome Therapeutics Provides Preliminary Fourth Quarter and Full Year 2024 Net Revenue
-
Akero Therapeutics Completes Enrollment of the Double-Blind Portion of the Phase 3 SYNCHRONY Real-World Study Evaluating Efruxifermin (EFX) in Patients with Non-Invasively Diagnosed MASH or MASLD
-
Five Below, Inc. Announces Holiday Sales Results for Quarter-To-Date Through January 4, 2025
-
Verve Therapeutics Announces Pipeline Progress and Anticipated 2025 Milestones
-
ADMA Biologics Announces Preliminary Full Year 2024 Revenue and Provides Business Update
-
Abercrombie & Fitch Co. Increases Fourth Quarter and Full Year Net Sales Outlook on Better-Than-Expected Holiday Sales
-
Travere Therapeutics Provides Corporate Update and 2025 Outlook
-
Autolus Therapeutics Provides Business Updates and 2025 Overview
-
Destination XL Group, Inc. Reports Holiday Sales Results
-
Fractyl Health Announces Positive Initial Clinical Results Demonstrating Weight Maintenance Following GLP-1 Discontinuation and Revita Procedure in First Patient of the REVEAL-1 Cohort
-
Aquestive Therapeutics Provides Business Update and Outlines Key 2025 Objectives
-
Foghorn Therapeutics Highlights Program Progress and Strategic Objectives for 2025
-
Vera Therapeutics Acquires Global Rights to Novel, Next Generation Dual BAFF/APRIL Inhibitor
-
iBio Announces New Investments from Board Members and Officers
-
Braves Announce Exclusive Gray Media Spring Training Action
-
Beam Therapeutics Announces Progress in Hematology and Genetic Disease Franchises and Outlines Key 2025 Anticipated Catalysts
-
Oatly to Report Fourth Quarter 2024 Financial Results on February 12, 2025
-
Mastercard and FreedomPay Unlock Global Commerce With New Payment Gateway Partnership
-
Amphista Therapeutics appoints Paul Medeiros as Chief Business Officer
-
EDAP Announces Preliminary Record Fourth Quarter Focal One® System Sales and Record U.S. Procedures
-
ClearView Healthcare Partners Makes Strategic Investment in Epistemic AI to Advance Next-Generation Biomedical AI Platform
-
George Medicines signs exclusive licensing agreement with Bausch Health to commercialize GMRx2 in Canada, Mexico, Columbia and Central America
-
Schouw & Co. share buy-back programme, week 2 2025
-
Avacta Appoints Brian Hahn as Chief Financial Officer
-
Devon Energy Announces Updates to Executive Leadership Team
-
Alamos Gold Continues to Define High-Grade Mineralization Across the Island Gold Deposit; Ongoing Success Expected to Drive Additional Growth in Mineral Reserves and Resources
